Literature DB >> 8301103

Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension.

C Ferrier1, G L Jennings, G Eisenhofer, G Lambert, H S Cox, V Kalff, M Kelly, M D Esler.   

Abstract

OBJECTIVE: To test whether the activation of the sympathetic nervous system that is common in essential hypertension derives from subcortical noradrenergic neuronal excitation. DESIGN AND METHODS: We performed a radionuclide cerebral venous sinus scan, using technetium-99m, to establish which internal jugular vein predominantly drained the cortical (the major jugular vein) and which the subcortical (minor jugular vein) brain regions. Blood samples were then collected simultaneously from catheters placed percutaneously in the brachial artery or radial artery and high in the internal jugular vein in 11 untreated hypertensive patients and 18 normotensive subjects, for determination of the plasma concentrations of noradrenaline, its precursor dihydroxyphenylalanine (DOPA) and its metabolite dihydroxyphenylglycol (DHPG) to calculate their rates of overflow into the cerebrovascular circulation.
RESULTS: In normotensive subjects blood flow determined by thermodilution was significantly higher in the major than in the minor jugular vein. The noradrenaline spillovers into the major and minor jugular veins calculated during infusions of L-[3H]-7-noradrenaline were similar in healthy subjects. The noradrenaline spillover from subcortical regions into the minor jugular vein was significantly higher in the hypertensives than in the normal subjects, as was the overflow of DHPG. In contrast, cortical noradrenaline and DHPG overflows into the major jugular vein were similar in hypertensive and normotensive subjects. Overflow of DOPA into the minor jugular vein, which derives largely from precursor turnover in dopaminergic neurons, was similar in hypertensive and normotensive subjects. Subcortical noradrenaline spillover correlated with neurochemical indices of sympathetic nervous system activity, with total body noradrenaline spillover (r = 0.56, P < 0.05) in normal and hypertensive subjects combined, and with renal noradrenaline spillover in the six hypertensive patients tested (r = 0.91, P < 0.05).
CONCLUSION: These results suggest that increased subcortical noradrenaline release is a possible cause of peripheral sympathetic activation in essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8301103

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  18 in total

Review 1.  Role of the Sympathetic Nervous System in Stress-Mediated Cardiovascular Disease.

Authors:  Dagmara Hering; Kamila Lachowska; Markus Schlaich
Journal:  Curr Hypertens Rep       Date:  2015-10       Impact factor: 5.369

Review 2.  New approaches to quantifying sympathetic nerve activity.

Authors:  Sandra L Burke; Elisabeth Lambert; Geoffrey A Head
Journal:  Curr Hypertens Rep       Date:  2011-06       Impact factor: 5.369

Review 3.  Sympathoneural and adrenomedullary responses to mental stress.

Authors:  Jason R Carter; David S Goldstein
Journal:  Compr Physiol       Date:  2015-01       Impact factor: 9.090

4.  Acute response to intracisternal bupivacaine in patients with refractory pain of the head and neck.

Authors:  Gavin Lambert; Mikael Elam; Peter Friberg; Christopher Lundborg; Sinsia Gao; Jonas Bergquist; Petre Nitescu
Journal:  J Physiol       Date:  2005-10-27       Impact factor: 5.182

Review 5.  The Role of Central Nervous System Mechanisms in Resistant Hypertension.

Authors:  Dagmara Hering; Markus Schlaich
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

Review 6.  Central nervous system norepinephrine metabolism in hypertension.

Authors:  G W Lambert
Journal:  Curr Hypertens Rep       Date:  2000-06       Impact factor: 5.369

Review 7.  Neural mechanisms and management of obesity-related hypertension.

Authors:  Murray D Esler; Nina Eikelis; Elisabeth Lambert; Nora Straznicky
Journal:  Curr Cardiol Rep       Date:  2008-11       Impact factor: 2.931

8.  Jugular venous overflow of noradrenaline from the brain: a neurochemical indicator of cerebrovascular sympathetic nerve activity in humans.

Authors:  David A Mitchell; Gavin Lambert; Niels H Secher; Peter B Raven; Johannes van Lieshout; Murray D Esler
Journal:  J Physiol       Date:  2009-04-29       Impact factor: 5.182

9.  Impaired purinergic neurotransmission to mesenteric arteries in deoxycorticosterone acetate-salt hypertensive rats.

Authors:  Stacie L Demel; James J Galligan
Journal:  Hypertension       Date:  2008-07-07       Impact factor: 10.190

10.  L-arginine supplementation reduces cardiac noradrenergic neurotransmission in spontaneously hypertensive rats.

Authors:  Chee-Wan Lee; Dan Li; Keith M Channon; David J Paterson
Journal:  J Mol Cell Cardiol       Date:  2009-04-09       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.